New drug duo enters fight against advanced liver cancer

NCT ID NCT07291076

Recruiting now Disease control Sponsor: Bristol-Myers Squibb Source: ClinicalTrials.gov ↗

Summary

This study is testing a new drug called pumitamig, both by itself and combined with an existing drug (ipilimumab), for people with advanced liver cancer that cannot be removed by surgery. The main goals are to see if these treatments are safe and if they can shrink tumors. It is for patients who have not yet received any drug treatment for their advanced cancer.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Locations

Hammersmith Hospital
RECRUITING

London, London, City of, W12 0HS, United Kingdom

Contact Phone: •••-•••-••••
John Theurer Cancer Center at Hackensack University Medical Center
RECRUITING

Hackensack, New Jersey, 07601, United States

Contact Phone: •••-•••-••••
Local Institution - 0003
NOT_YET_RECRUITING

Bobigny, 93000, France

Contact
Local Institution - 0004
NOT_YET_RECRUITING

Grenoble, Isère, 38043, France

Contact
Local Institution - 0006
NOT_YET_RECRUITING

Taipei, 100229, Taiwan

Contact
Local Institution - 0009
NOT_YET_RECRUITING

Singapore, 119074, Singapore

Contact
Local Institution - 0011
NOT_YET_RECRUITING

Seoul, Seoul-teukbyeolsi, 05505, South Korea

Contact
Local Institution - 0012
NOT_YET_RECRUITING

Singapore, 169610, Singapore

Contact
Local Institution - 0013
NOT_YET_RECRUITING

Seoul, Seoul Teugbyeolsi, 06351, South Korea

Contact
Local Institution - 0014
NOT_YET_RECRUITING

Pamplona, Navarre, 31008, Spain

Contact
Local Institution - 0016
NOT_YET_RECRUITING

Pisa, 56126, Italy

Contact
Local Institution - 0018
NOT_YET_RECRUITING

Saint Priest En Jarez, Pays de la Loire Region, 42270, France

Contact
Local Institution - 0020
NOT_YET_RECRUITING

Gdansk, 80-952, Poland

Contact
Local Institution - 0021
NOT_YET_RECRUITING

Wroclaw, Lower Silesian Voivodeship, 53-439, Poland

Contact
Local Institution - 0022
NOT_YET_RECRUITING

Nashville, Tennessee, 37203, United States

Contact
Local Institution - 0024
NOT_YET_RECRUITING

Camperdown, New South Wales, 2050, Australia

Contact
Local Institution - 0027
NOT_YET_RECRUITING

Seongnam-si, Gyeonggi-do, 13496, South Korea

Contact
Local Institution - 0028
NOT_YET_RECRUITING

Kiel, Schleswig-Holstein, 24105, Germany

Contact
Local Institution - 0030
NOT_YET_RECRUITING

Frankfurt, D-60590, Germany

Contact
Local Institution - 0031
NOT_YET_RECRUITING

Cologne, North Rhine-Westphalia, 50937, Germany

Contact
Local Institution - 0032
NOT_YET_RECRUITING

Taichung, 404332, Taiwan

Contact
Local Institution - 0033
NOT_YET_RECRUITING

Westmead, New South Wales, 2145, Australia

Contact
Local Institution - 0040
NOT_YET_RECRUITING

Birtinya, Queensland, 4575, Australia

Contact
Local Institution - 0046
NOT_YET_RECRUITING

Rozzano (MI), 20089, Italy

Contact
Local Institution - 0051
NOT_YET_RECRUITING

Glasgow, South Western Scotland, G611BD, United Kingdom

Contact
Local Institution - 0053
NOT_YET_RECRUITING

Metropolitan Borough of Wirral, CH63 4JY, United Kingdom

Contact
Local Institution - 0055
NOT_YET_RECRUITING

Tainan, Taiana, 704, Taiwan

Contact
Local Institution - 0056
NOT_YET_RECRUITING

Pessac, Aquitaine, 33600, France

Contact
Local Institution - 0060
NOT_YET_RECRUITING

Madrid, 28028, Spain

Contact
Local Institution - 0064
NOT_YET_RECRUITING

Santiago, Santiago Metropolitan, 8420383, Chile

Contact
Local Institution - 0070
NOT_YET_RECRUITING

Los Angeles, California, 90064, United States

Contact
Local Institution - 0075
NOT_YET_RECRUITING

Guangzhou, Guangdong, 510515, China

Contact
Local Institution - 0078
NOT_YET_RECRUITING

Shanghai, Shanghai Municipality, 200032, China

Contact
Local Institution - 0080
NOT_YET_RECRUITING

Portland, Oregon, 97213, United States

Contact
Local Institution - 0083
NOT_YET_RECRUITING

Seattle, Washington, 98109-1024, United States

Contact
Local Institution - 0086
NOT_YET_RECRUITING

Xi'an, Shaanxi, 710126, China

Contact
Local Institution - 0088
NOT_YET_RECRUITING

Milan, 20, Italy

Contact
Local Institution - 0096
NOT_YET_RECRUITING

Melbourne, 3002, Australia

Contact
Local Institution - 0100
NOT_YET_RECRUITING

Great Neck, New York, 11021, United States

Contact
Local Institution - 0102
NOT_YET_RECRUITING

Nashville, Tennessee, 37232, United States

Contact
Local Institution - 0105
NOT_YET_RECRUITING

Warsaw, Masovian Voivodeship, 02-106, Poland

Contact
Local Institution - 0106
NOT_YET_RECRUITING

Santiago Region Metropolitana, Santiago Metropolitan, 8330034, Chile

Contact
Local Institution - 0107
NOT_YET_RECRUITING

Chicago, Illinois, 60611, United States

Contact
Local Institution - 0109
NOT_YET_RECRUITING

Pisa, Tuscany, 56126, Italy

Contact
Taipei Veterans General Hospital
RECRUITING

Taipei, 11217, Taiwan

Contact Phone: •••-•••-••••

Conditions

Explore the condition pages connected to this study.

HEPATOCELLULAR CARCINOMA (HCC)